Validation of Myc-Associated Protein X (MAX) regulation in growth hormone secreting and nonfunctional pituitary adenoma.
Tucker DW, Pangal DJ, Du R, Gogia AS, Tafreshi A, Ruzevick J, Hurth KT, Triche T Jr, Micko A, Carpten JD, Shiroishi MS, Carmichael JD, Rhie SK, Zada G.
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors.
Bianchi A, Chiloiro S, Giampietro A, Gaudino S, Calandrelli R, Mazzarella C, Caldarella C, Rigante M, Gessi M, Lauretti L, De Marinis L, Olivi A, Pontecorvi A, Doglietto F.
Front Endocrinol (Lausanne). 2023 May 3;14:1123267. doi: 10.3389/fendo.2023.1123267. eCollection 2023.
PMID:37206441
Plurihormonal pituitary adenoma with concomitant adrenocorticotropic hormone (ACTH) and growth hormone (GH) secretion: a report of two cases and review of the literature.
Rasul FT, Jaunmuktane Z, Khan AA, Phadke R, Powell M.
Clin Med (Lond). 2003 Jan-Feb;3(1):15-9. doi: 10.7861/clinmedicine.3-1-15.
PMID:12617407
Perioperative hormone level changes and their clinical implications in patients with pituitary adenoma: a retrospective study of 428 cases at a single center.
Zhao M, Li K, Niu H, Zhao Y, Lu C.
Front Endocrinol (Lausanne). 2023 Oct 30;14:1286020. doi: 10.3389/fendo.2023.1286020. eCollection 2023.